In the study, nicergoline was compared with imidapril, an angiotensin-converting enzyme inhibitor that has been known to improve swallowing reflex by raising substance P levels in persons with dysphagia [33] and lowering the risk of pneumonia [34]. The gene discussed is TAC1; the disease is susceptibility to pneumonia measurement.